Histological Findings in Testes of Baboons (Papio spp.) and Dwarf Bucks (Capra hircus) Subject to Repeated Immunisation Against GnRH Authors: Teresa Ferrín, Eva Martínez‐Nevado, Juncal García, Adolfo Toledano‐Díaz, Rosario Velázquez, Esther Alba, Cristina Castaño, Belén Martinez‐Madrid, Julián Santiago‐Moreno Published: 2026 ABSTRACT ABSTRACTBackgroundImmunocontraception is a population management strategy based on vaccines that induce an immune response against reproductive targets such as GnRH.ObjectivesThis study aimed to investigate spermatogenic activity in adult baboons and adult dwarf bucks subject to repeated immunisation against GnRH for extended periods.MethodsIn Experiment 1, histological findings in untreated dwarf bucks (CONTROL‐1) (n = 10) were compared with those found in males repeatedly immunised against GnRH (Improvac) during 5 years (RI‐1; n = 15). In Experiment 2, one group of baboons received immunocontraceptive treatment against GnRH during 5–10 years until death (RI‑2; n = 6). The second group received the same treatment for 10 years before discontinuation, with the interval between treatment withdrawal and death ranging from 10 to 27 months (RI‑2+S; n = 19). As in Experiment 1, testicular tissue was collected post‐mortem and processed histologically.ResultsIn both species, the testicular tissue of animals treated with repeated immunisation against GnRH showed an absence of active spermatogenesis. The mean seminiferous tubule diameter in bucks was smaller in the RI‐1 group than in the CONTROL‐1 group (108.69 ± 13.17 µm vs. 187.35 ± 14.38 µm; p < 0.05). In baboons, morphometric analysis showed similar seminiferous tubule diameters in the RI‐2 (82.63 ± 4.47 µm) and RI‐2+S (79.23 ± 5.89 µm) groups.ConclusionsIn bucks and in more than 70% of baboons, the severity of degenerative changes in the germinal epithelium suggests that long‐term repeated immunisation against GnRH may lead to irreversible infertility.Keywords: GnRH vaccine, male immunocontraceptive, spermatogenesis, testes Introduction Wildlife contraception is a widely accepted strategy for managing populations of wild animal species, contributing to improved animal welfare (Liedholm et al. 2024). Effective reproduction management is essential for maintaining the health and well‐being of wild animals housed in zoos, particularly when high reproductive rates pose challenges related to limited space or welfare concerns. Although surgical castration of males is commonly employed to prevent unintended pregnancies and mitigate issues associated with libido and aggressive behaviour, this procedure entails surgical risks and raises ethical and welfare considerations. Consequently, alternative contraceptive strategies that provide reversible effects have been developed and implemented as suitable options (Garside et al. 2014). In females, antiprogestagens for punctual leading to pregnancy interruption (Bigsby 1990) and progestogens for temporarily inhibiting reproductive function (Munson et al. 2002) have been widely used, albeit concern has been raised about possible pathology in progestin‐treated carnivores (Kollias 1988). Another widely used hormonal contraceptive treatment involves gonadotrophin‐releasing hormone (GnRH) agonists, such as deslorelin. Its administration, usually through subcutaneous implants, initially induces an increase in the concentrations of follicle‐stimulating hormone (FSH) and luteinising hormone (LH) (‘flare‐up effect’) followed by a suppression of the hypothalamic–pituitary–gonadal axis, by desensitisation of the GnRH receptors to GnRH, leading to inhibition of testosterone and oestrogens in males and females (Lucas 2014). For use exclusively in males, cyproterone acetate, a steroid anti‐androgen that specifically blocks the effects of androgens in all the target organs, induces reversible endocrine and spermatogenic disruption in ruminants (Flores‐Gil et al. 2020). However, prolonged administration of this drug has been associated with the development of mammary carcinomas (Spugnini et al. 2010). Finally, immunocontraception represents a relatively novel population control strategy, involving the use of vaccines that stimulate an immune response against key reproductive proteins, such as zona pellucida proteins or GnRH (Kirkpatrick et al. 1995, 1996). Active immunisation against GnRH suppresses hypothalamic GnRH synthesis and secretion (Han et al. 2017). Consequently, LH secretion is not stimulated, leading to reduced testosterone secretion by Leydig cells. The fall of testosterone blood levels results in testicular atrophy, inhibition of spermatogenesis and impaired sperm quality (Ajadi and Oyeyemi 2015; Lincoln et al. 1982; Nuñez Favre et al. 2018). These vaccines have been investigated as an immunocontraceptive treatment in males of a wide number of both domestic (Kiyma et al. 2000; Giriboni et al. 2023; Fuchs et al. 2009) and wild species (Killian et al. 2006; Lueders et al. 2017; Schwarzenberger et al. 2022; Martinez‐Gimenez et al. 2021). Active immunisation against GnRH is particularly suitable for free‐ranging wildlife (Miller et al. 2004), and for domestic species, as well as a population control method for wildlife in zoos, where handling the animals for booster doses to prolong the initially reversible and highly effective contraceptive effect is not problematic. However, the effects of prolonged active immunisation against GnRH on spermatogenic function remain poorly characterized, and the issue of reversibility remains unsolved (Schwarzenberger et al. 2022). Sustained suppression of gonadotropin secretion over an extended period may cause severe alterations to the nuclear membrane of Sertoli cells and the mitochondrial structure of Leydig cells, as well as disruption of the germinal epithelium (Li et al. 2013), which could ultimately result in permanent infertility. Dwarf goats (Capra hircus) are commonly found in petting zoos and are easy to handle, making them a useful experimental model for studying the effects of contraceptive treatments on testicular function in wild ruminants (Giriboni et al. 2020, 2023). Baboon species (Papio spp.) are common primates in zoos. They exhibit polygynous sexual behaviour with high testicular activity (Bercovitch 1989), making them a suitable animal model for evaluating contraceptive treatments that could be applied to other primate species. This study aimed to evaluate spermatogenic function in dwarf bucks and baboons subjected to repeated GnRH immunisation over an extended period, in order to assess the reversibility of this treatment. Materials and Methods Animals and Experimental Design This study was conducted on adult male dwarf goats (Capra hircus) (n = 25) and baboons (Papio spp) (n = 25) housed at the Zoo Aquarium of Madrid (ZAM). In both species, repeated immunocontraception was achieved by active immunisation against GnRH using the commercial vaccine Improvac (Zoetis Inc). Animals received an initial intramuscular injection of 2 mL of Improvac containing 300 µg GnRH analog as a protein‐conjugate with diphtheria toxoid, by manual injection in goats and by manual injection in a squeeze cage or blowpipe dart injection in baboons, followed by a booster 4 weeks later and subsequent revaccinations at 6‐month intervals until either treatment cessation or death. Individual animal data from both experiments, including age at first vaccination, age at last vaccination and the interval between the last vaccination and death, are provided in Tables S1–S2. Experiment 1. Evaluation of Repeated Immunocontraceptive Treatment in Male Dwarf Goats Histological findings in untreated animals (CONTROL‐1) (n = 10) were compared with those found in males repeatedly treated with immunocontraception during 5 years (RI‐1) (n = 15). Animals in the RI‐1 group began contraceptive treatment between 1.5 and 6 years of age. Upon natural death of all individuals, testicular tissue was retrieved for subsequent histological processing. The interval between the end of treatment and natural death ranged from 1 to 7 years. Experiment 2. Evaluation of Repeated Immunocontraceptive Treatment in Male Baboons One group of baboons received immunocontraceptive treatment against GnRH during 5–10 years until death (RI‑2; n = 6). The second experimental group received the same treatment for 10 years before discontinuation (RI‑2+S; n = 19), with the interval between treatment withdrawal and death ranging from 10 to 27 months. The length of treatment in each case was determined by the timing of natural death relative to the immunisation period. As in Experiment 1, testicular tissue was collected post‐mortem and processed histologically. Histological and Morphometric Assessment of Testicular Tissue Testicular tissue samples were collected by the veterinary team at ZAM following the natural death of the study animals, and processed at the Laboratory of Histology at the Department of Animal Reproduction, INIA–CSIC. Histological samples were randomly collected from either the left or the right testis at the mid‐testicular region, after confirming the absence of asymmetry or differences in texture between testes. Samples were fixed in Bouin's solution for 24–48 h, followed by 70% ethanol before being embedded in paraffin wax. Four‐micrometer sections were obtained for histological and morphometrical evaluation and stained with standard haematoxylin and eosin. Histological and morphometrical evaluation was made using Motic Image Advanced v.3.0 software, under bright‐field microscopy (Motic BA210) at 4X, 10X and 40X magnifications. The presence of germ and somatic cells, histopathological alterations and seminiferous tubule morphometry were evaluated. For each seminiferous tubule, both major and minor diameters were measured, and 25 tubules were analysed per sample (Martínez‐Fresneda et al. 2019). Histological examination revealed limited heterogeneity among seminiferous tubules within each testis, even in samples displaying degenerative changes. Therefore, the evaluation of 25 seminiferous tubule cross‐sections was considered representative of the overall histological status of each sample. Statistical Analysis In both experiments, given the small sample size and the non‐normal distribution of values, statistical comparisons between groups were performed using the non‐parametric Mann–Whitney U test. All analyses were conducted using TIBCO Statistica Version 14.0, and statistical significance was set at p < 0.05. Data were expressed as the mean ± standard error of the mean (SEM). Results Efficacy of Repeated Immunocontraceptive Treatment in Male Dwarf Goats In the CONTROL‐1 group, no histological alterations were observed in the testicular tissue of any of the animals examined. In the seminiferous epithelium, Sertoli cells were identified, along with the full range of germ cell types (spermatogonia, spermatocytes, round spermatids and elongated spermatids), as well as spermatozoa within the tubular lumen (Figure 1). Leydig cells were also observed in the interstitial space (Figure 1, left panel). Testicular tissue from adult male dwarf goats in the CONTROL‐1 group, showing active spermatogenesis with the presence of spermatozoa within the lumen of the seminiferous tubules (spermatozoa, spz; Leydig cells, Lc; spermatid, sd; spermatocyte, Sc; Spermatogonia, Spg). Left: 100×. Right: 400×. Haematoxylin–eosin staining. In the RI‐1 group, histological examination revealed a reduced tubular lumen with complete absence of germ cells (with the occasional presence of spermatogonia), or germ cells with advanced pyknosis, karyorrhexis and karyolysis. Multinucleated spermatids, vacuolization of germ cells and tubular hyalinization were also seen. These findings were consistent with severe testicular degeneration and atrophy. Neither Sertoli nor Leydig cells were detected in any of the samples (Figure 2). Furthermore, a marked increase in interstitial space with inflammatory infiltrates was observed (Figure 3). A marked interindividual variability in the degree of testicular damage was evident among bucks. Histological alterations in testicular tissue of adult male dwarf goats of the RI‐1 group (repeated immunocontraception treatment). Left: Pyknosis (pk) and multinucleated spermatids (→). Right: Vacuolization (*) of the tubular epithelium. Haematoxylin–eosin staining, 100X. Histological alterations in testicular tissue of adult male dwarf goats of the RI‐1 group (repeated immunocontraception treatment). Degeneration of seminiferous epithelium with inflammatory infiltrates in interstitial space (→). Haematoxylin–eosin staining, 100X. Morphometric analysis revealed that the mean seminiferous tubule diameter was smaller in the RI‐1 group than in the CONTROL‐1 group (108.69 ± 13.17 µm vs. 187.35 ± 14.38 µm; p < 0.05). Efficacy of Repeated Immunocontraceptive Treatment in Male Baboons In all baboons subjected to repeated immunocontraception, histological findings were consistent: Germ cells were absent, or present only as occasional spermatogonia and spermatocytes, most of which exhibited pyknosis, karyorrhexis and karyolysis. Isolated Sertoli cells were only detected in some animals. Pronounced testicular atrophy, hyalinisation and vacuolisation of the seminiferous epithelium were observed. An increase in interstitial space accompanied by inflammatory infiltration and narrowing of the tubular lumen was also observed. No histological differences attributable to treatment suspension were detected between groups. Histological examination revealed limited heterogeneity among seminiferous tubules within each testis, as observed in bucks from the previous experiment, even in samples exhibiting severe degenerative changes. However, marked interindividual variability in the degree of testicular damage was evident among baboons, including complete hyalinisation of seminiferous tubules devoid of cells in some individuals, predominance of pyknotic cells in others, and basal hyalinization with residual spermatocytes and vacuolization in others (Figure 4). In 18 of 25 baboons (72%) of the RI‑2+S group, the damage consisted of full hyalinisation and practically acellular seminiferous ducts, compatible with irreversible damage. Histological alterations in testicular tissue of adult male baboons. Left: RI‐2 group (repeated immunocontraception treatment) showing hyalinization of all seminiferous tubules (→). Right: IR‐2+S group (repeated immunization treatment followed by discontinuation) showing vacuolization of the tubules (→). These lesions were observed indistinctly in both groups. Haematoxylin–eosin staining, 100X. Morphometric analysis revealed a mean seminiferous tubule diameter of 82.63 ± 4.47 µm in the RI‐2 group and 79.23 ± 5.89 µm in the RI‐2+S group, with no significant differences between them. Discussion These results suggest that repeated immunisation against GnRH in sexually mature bucks for at least 5 years, and in baboons for 10 years, induces irreversible contraceptive effects. The anti‐GnRH vaccine used in this study was originally developed to suppress boar taint in swine carcasses by temporarily inhibiting spermatogenic and steroidogenic testicular function (Einarsson et al. 2009). Specifically, Improvac was developed by Zoetis to inhibit the synthesis of androstenone, the compound responsible for boar taint, and testosterone, while maintaining residual androgen levels that support growth. This treatment reduces sexual and aggressive behaviours typically observed in entire males (Dunshea et al. 2001; Zamaratskaia et al. 2008). Immunisation against GnRH acts on the hypothalamic–pituitary–testicular axis, resulting in a marked reduction in FSH and LH concentrations (Fuchs et al. 2009). This suppression leads to decreased testicular weight, reduced size of bulbourethral glands, diminished numbers of Leydig cells and an increase in sperm abnormalities, culminating in azoospermia (Einarsson et al. 2009). In a previous study, Giriboni et al. (2020) compared subcutaneous implants of the GnRH agonist deslorelin with a single immunocontraceptive treatment using Improvac (primary vaccination plus booster after 4 weeks) in adult dwarf goats. Neither treatment achieved complete azoospermia or testosterone suppression to undetectable levels, although deslorelin implants appeared to be more effective for long‐term suppression of reproductive function, as they induced a greater reduction in plasma testosterone and sperm counts. However, in that study, immunisation was limited to two doses only. Similarly, Godfrey et al. (1996) immunised feral‐origin goat bucks against GnRH using two vaccine doses, which effectively prevented the seasonal rise in FSH, LH and testosterone. This intervention resulted in reduced testicular size, diminished sexual odour and lower sperm production; however, complete azoospermia was not achieved either. To investigate whether extending treatment duration and dosage might enhance contraceptive efficacy, Giriboni et al. (2023) compared single‐dose immunocontraception (primary plus booster), repeated treatment for 3 years (primary, booster after 4 weeks and revaccinations every 6 months), and untreated controls in adult dwarf goats. The results demonstrated that 3 years of repeated immunisation markedly impaired testicular function, reducing scrotal circumference, plasma testosterone concentration, sexual odour and semen quality, but did not achieve complete suppression of spermatogenesis. Animals treated for 3 years exhibited a condition similar to that of fertile males during the non‐breeding season. Conversely, a single treatment (two doses only) failed to induce the expected contraceptive response. In the present study, repeated immunocontraceptive treatment in bucks lasted for 5 years, compared with 3 years in Giriboni et al. (2023). The extended treatment duration likely accounts for the complete suppression of spermatogenic activity observed in this study, characterised by the total absence of histologically normal germ cells, including spermatozoa, and pronounced degenerative alterations in the seminiferous tubules, such as severe atrophy, hyalinisation and vacuolisation. Inactivation of pituitary function and persistently low basal testosterone levels appear to impair Sertoli and Leydig cells, which were absent in many of the examined samples. Indeed, plasma FSH concentrations are markedly suppressed in small ruminants immunised against GnRH (Brown et al. 1994), which accounts for the impairment of Sertoli cell function and the subsequent disruption of spermatogenesis. In a previous study in ram lambs immunised against GnRH, histological analysis revealed testicular atrophy and a reduction in seminiferous tubule diameter, along with the absence of spermatozoa in many treated animals (Kiyma et al. 2000). However, all of these pathological changes were less severe than those observed in the bucks subjected to repeated immunisation in our study. These findings suggest that complete contraception in ruminants requires prolonged and repeated immunisation to fully suppress spermatogenic activity. Our findings in baboons were consistent with observations in male giraffes (Giraffa camelopardalis) treated with repeated immunisation against GnRH for over 2 years, where faecal testosterone levels and testicular size failed to return to pre‐treatment values even after 4 years of treatment suspension (Schwarzenberger et al. 2022). In African elephants (Loxodonta africana), repeated GnRH vaccination over 2–4 years has yielded promising results (Lueders et al. 2017), with a 40% reduction in testicular size at the end of treatment and azoospermic or immotile ejaculates after the first year. A review of published and unpublished studies in African elephants concluded that irreversible effects may occur after more than 2–3 years of repeated treatment (4–8 doses), with male age at first treatment influencing the likelihood of reversibility, at least in relation to androgen‐dependent behaviours (Bertschinger and Lueders 2018). Taken together, available evidence suggests that the duration of repeated immunisation against GnRH treatment required to induce irreversible contraception varies between species: about 10 years in baboons in the current study, 5 years in dwarf goats and as little as 3 years in giraffes. However, only limited studies have been conducted, largely due to the inherent challenges of carrying out long‐term immunocontraception trials in wild species. Further research is therefore needed to inform population management strategies in zoos and wildlife reserves. It is noteworthy that most immunocontraception studies have assessed treatment efficacy using plasma or faecal testosterone levels, testicular and accessory gland size, and semen quality. Histological evaluation of testicular damage, however, has rarely been reported and represents the most objective assessment of spermatogenic activity. After a single‐course immunisation (primary plus booster) in pigs, histological alterations of the germinal epithelium and Leydig cells have been observed (Einarsson et al. 2009), while in broiler cockerels a reduction in germinal epithelium height has been described (Wang et al. 2019). To our knowledge, the present study is the first to conduct a comprehensive histological and morphometric evaluation of testicular tissue following long‐term repeated immunocontraception. Our findings suggest that the period of treatment required for complete disruption of spermatogenesis varies according to the species. Therefore, it is recommended that zoos employing immunocontraception for population control should systematically preserve testicular tissue after the death of treated animals, in order to enable subsequent histological and morphometric studies. Conclusions The severity of degenerative changes in the germinal epithelium suggests that repeated immunisation against GnRH for a long time may induce irreversible infertility in dwarf bucks and baboons. Because this repeated treatment ultimately arrests spermatogenesis, it is considered an effective contraceptive treatment. Both species were used as experimental animal models; therefore, a comparable physiological response can be anticipated in other bovid and primate species. Histological assessment of spermatogenic activity is recommended in deceased zoo animals subjected to contraceptive treatments to objectively evaluate the irreversibility of the treatments. Author Contributions Teresa Ferrín : writing – original draft, methodology, formal analysis. Eva Martínez‐Nevado : conceptualization, investigation, methodology, validation, writing – review and editing, resources. Juncal García : investigation, methodology, validation, resources. Adolfo Toledano‐Díaz : investigation, methodology, validation, writing – review and editing. Rosario Velázquez : methodology, validation. Esther Alba : methodology, validation, formal analysis. Cristina Castaño : methodology, validation. Belén Martinez‐Madrid : investigation, writing – original draft, methodology, validation, writing – review and editing, formal analysis, data curation, supervision. Julián Santiago‐Moreno : conceptualization, investigation, funding acquisition, writing – review and editing, project administration, data curation, supervision. Funding This study was funded through the Research and Development Agreement between Fundación Parques Reunidos and INIA–CSIC (Ref. CID24‐207). Part of this study was supported by the project PID2023‐146957OB‐I00, funded by MICIU/AEI/10.13039/501100011033 and FEDER UE. Ethics statement All animals were managed in ways consistent with the Spanish Policy for Animal Protection (RD53/2013), which conforms to European Union Directive 86/609 regarding the protection of animals used in scientific experiments. All procedures of this study were evaluated and approved by the internal animal welfare committee based on the EAZA (European Association of Zoos and Aquariums) Code of Ethics. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Supporting File: vms371239‐sup‐0001‐SuppMat.docx. Data Availability Statement The data that support the findings of this study are openly available in Supplementary Data: Histological Images of Testes from GnRH‐ at http://hdl.handle.net/10261/440090. References Associated Data Supplementary Materials Supporting File: vms371239‐sup‐0001‐SuppMat.docx. Data Availability Statement The data that support the findings of this study are openly available in Supplementary Data: Histological Images of Testes from GnRH‐ at http://hdl.handle.net/10261/440090.